Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study-Reference-Cited by-同舟云学术

Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study

Published:2020-04-16 Issue:11 Volume:16 Page:2656-2662
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Motaze N. V.¹²^ORCID,Makhathini L.¹,Smit S. B.¹,Adu-Gyamfi C. G.¹³,Fortuin M.¹,Wiysonge C. S.²⁴^ORCID,Suchard S. M.¹³^ORCID

Affiliation:

1. A Division of the National Health Laboratory Service, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa

2. Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa

3. Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

4. Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa

Funder

Ernest Oppenheimer Memorial Trust

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1738834

Reference32 articles.

1. World Health Organization. Global measles and rubella strategic plan: 2012–2020. [Internet]. 2012 [accessed 2017 Jan 23]. http://apps.who.int/iris/bitstream/10665/44855/1/9789241503396%5Feng.pdf

2. Measles and Rubella Global Strategic Plan 2012–2020 midterm review

3. Endean C (ed.). Gavi Progress Report 2015. The Global Alliance for Vaccines and Immunization; 2015. Report No.: 2016.

4. Motaze NV, Suchard M, Cohen C, Baker L, Blumberg L (eds), Vaccine information for parents & caregivers [Internet]. Johannesburg: Ideas Wise and Wonderful for National Institute for Communicable Diseases; 2016 [accessed 2018 Feb 15]. http://www.nicd.ac.za/assets/files/NICD_Vaccine_Booklet_D132_FINAL.pdf

5. Organization WH, others. Immunological basis for immunization: rubella. 2008 [accessed 2017 Jan 22]. http://apps.who.int/iris/handle/10665/43922

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies;The American Journal of Tropical Medicine and Hygiene;2024-07-03

2. Evaluation of the rubella surveillance system in South Africa, 2016–2018: A cross-sectional study;PLOS ONE;2023-06-23

3. Rubella Vaccines;Plotkin's Vaccines;2023

4. A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine;PLOS ONE;2022-05-05